Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 May;82(9):2598–2602. doi: 10.1073/pnas.82.9.2598

gamma-Fluoromethotrexate: synthesis and biological activity of a potent inhibitor of dihydrofolate reductase with greatly diminished ability to form poly-gamma-glutamates.

J Galivan, J Inglese, J J McGuire, Z Nimec, J K Coward
PMCID: PMC397611  PMID: 2581252

Abstract

A methotrexate (MTX) analog containing fluorine at the gamma-carbon of the glutamate moiety, gamma-fluoromethotrexate (FMTX), has been synthesized and evaluated for its biochemical and pharmacological properties. FMTX inhibition of dihydrofolate reductase from several sources is nearly equivalent to that shown by MTX. Most important, FMTX is an exceedingly poor substrate for folylpoly (gamma-glutamate) synthetase, the enzyme that catalyzes the biosynthesis of the highly-retained, cytotoxic MTX polyglutamates. Uptake experiments in H35 hepatoma cells show that FMTX accumulates to approximately the same extent as MTX at steady state. The rapid efflux of both derivatives is also very similar. The major difference detected in cells between the two compounds is the meager glutamylation of FMTX, due to the electronegative properties of the fluorine adjacent to the potential amide-forming carboxyl group. Exposure of dividing cells to 50 microM MTX for 2 and 6 hr results in the formation of 55 and 130 nmol, respectively, of the polyglutamates (more than two glutamate residues)/g of cell protein. With FMTX these values were reduced by 98% and 93%, respectively. Growth inhibition studies show that MTX is only 12-fold more toxic than FMTX when the cells are exposed to each derivative continuously for 72 hr. When the exposure time is reduced, a greater disparity between the inhibitory effects is observed; with a 2-hr pulse, MTX is 2300-fold more effective than FMTX. These data correlate with the effects of pulses of FMTX and MIX on de novo thymidylate biosynthesis in intact cells. The results indicate that of the parameters examined, the vastly reduced toxicity of FMTX after its removal from the culture medium is best correlated with impaired glutamylation. The data strongly suggest that prolonged toxicity of MTX is a result of metabolic conversion to MTX polyglutamates and that these effects are far more dramatic in short-term than in long-term exposure to the antifolates.

Full text

PDF
2598

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balinska M., Nimec Z., Galivan J. Characteristics of methotrexate polyglutamate formation in cultured hepatic cells. Arch Biochem Biophys. 1982 Jul;216(2):466–476. doi: 10.1016/0003-9861(82)90235-1. [DOI] [PubMed] [Google Scholar]
  2. Balińska M., Galivan J., Coward J. K. Efflux of methotrexate and its polyglutamate derivatives from hepatic cells in vitro. Cancer Res. 1981 Jul;41(7):2751–2756. [PubMed] [Google Scholar]
  3. Baugh C. M., Krumdieck C. L., Nair M. G. Polygammaglutamyl metabolites of methotrexate. Biochem Biophys Res Commun. 1973 May 1;52(1):27–34. doi: 10.1016/0006-291x(73)90949-2. [DOI] [PubMed] [Google Scholar]
  4. Bonney R. J., Maley F. Effect of methotrexate on thymidylate synthetase in cultured parenchymal cells isolated from regenerating rat liver. Cancer Res. 1975 Aug;35(8):1950–1956. [PubMed] [Google Scholar]
  5. Dunlap R. B., Gundersen L. E., Huennekens F. M. Interconversion of the multiple forms of dihydrofolate reductase from amethopterin-resistant Lactobacillus casei. Biochem Biophys Res Commun. 1971 Mar 5;42(5):772–777. doi: 10.1016/0006-291x(71)90495-5. [DOI] [PubMed] [Google Scholar]
  6. FU S. C., REINER M. A NEW SYNTHESIS OF P-METHYLAMINOBENZOLY-L-GLUTAMIC ACID. J Org Chem. 1965 Apr;30:1277–1278. [PubMed] [Google Scholar]
  7. Fabre I., Fabre G., Goldman I. D. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. Cancer Res. 1984 Aug;44(8):3190–3195. [PubMed] [Google Scholar]
  8. Fry D. W., Anderson L. A., Borst M., Goldman I. D. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity. Cancer Res. 1983 Mar;43(3):1087–1092. [PubMed] [Google Scholar]
  9. Fry D. W., Yalowich J. C., Goldman I. D. Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem. 1982 Feb 25;257(4):1890–1896. [PubMed] [Google Scholar]
  10. Galivan J. Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate. Mol Pharmacol. 1980 Jan;17(1):105–110. [PubMed] [Google Scholar]
  11. Galivan J., Nimec Z. Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates. Cancer Res. 1983 Feb;43(2):551–555. [PubMed] [Google Scholar]
  12. Galivan J. Transport and metabolism of methotrexate in normal and resistant cultured rat hepatoma cells. Cancer Res. 1979 Mar;39(3):735–743. [PubMed] [Google Scholar]
  13. Gewirtz D. A., White J. C., Randolph J. K., Goldman I. D. Formation of methotrexate polyglutamates in rat hepatocytes. Cancer Res. 1979 Aug;39(8):2914–2918. [PubMed] [Google Scholar]
  14. Jolivet J., Chabner B. A. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. J Clin Invest. 1983 Sep;72(3):773–778. doi: 10.1172/JCI111048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jolivet J., Schilsky R. L., Bailey B. D., Drake J. C., Chabner B. A. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. J Clin Invest. 1982 Aug;70(2):351–360. doi: 10.1172/JCI110624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McGuire J. J., Hsieh P., Coward J. K., Bertino J. R. Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products. J Biol Chem. 1980 Jun 25;255(12):5776–5788. [PubMed] [Google Scholar]
  17. McGuire J. J., Hsieh P., Coward J. K., Bertino J. R. In vitro methotrexate polyglutamate synthesis by rat liver folylpolyglutamate synthetase and inhibition by bromosulfophthalein. Adv Exp Med Biol. 1983;163:199–214. doi: 10.1007/978-1-4757-5241-0_16. [DOI] [PubMed] [Google Scholar]
  18. Nimec Z., Galivan J. Regulatory aspects of the glutamylation of methotrexate in cultured hepatoma cells. Arch Biochem Biophys. 1983 Oct 15;226(2):671–680. doi: 10.1016/0003-9861(83)90337-5. [DOI] [PubMed] [Google Scholar]
  19. Piper J. R., Montgomery J. A. Preparation of 6-(bromomethyl)-2,4-pteridinediamine hydrobromide and its use in improved syntheses of methotrexate and related compounds. J Org Chem. 1977 Jan 21;42(2):208–211. doi: 10.1021/jo00422a005. [DOI] [PubMed] [Google Scholar]
  20. Poser R. G., Sirotnak F. M., Chello P. L. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo. Cancer Res. 1981 Nov;41(11 Pt 1):4441–4446. [PubMed] [Google Scholar]
  21. Rosenblatt D. S., Whitehead V. M., Vera N., Pottier A., Dupont M., Vuchich M. J. Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured human cells. Mol Pharmacol. 1978 Nov;14(6):1143–1147. [PubMed] [Google Scholar]
  22. Schilsky R. L., Bailey B. D., Chabner B. A. Methotrexate polyglutamate synthesis by cultured human breast cancer cells. Proc Natl Acad Sci U S A. 1980 May;77(5):2919–2922. doi: 10.1073/pnas.77.5.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sirotnak F. M., Chello P. L., Piper J. R., Montgomery J. A. Growth inhibitory, transport and biochemical properties of the gamma-glutamyl and gamma-aspartyl peptides of methotrexate in L1210 leukemia cells in vitro. Biochem Pharmacol. 1978;27(14):1821–1825. doi: 10.1016/0006-2952(78)90025-4. [DOI] [PubMed] [Google Scholar]
  24. Sirotnak F. M., Donsbach R. C. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell. Cancer Res. 1972 Oct;32(10):2120–2126. [PubMed] [Google Scholar]
  25. Tarentino A. L., Galivan J. Membrane characteristics of adult rat liver parenchymal cells in primary monolayer culture. In Vitro. 1980 Oct;16(10):833–846. doi: 10.1007/BF02619420. [DOI] [PubMed] [Google Scholar]
  26. Tomich P. K., Chiu C. S., Wovcha M. G., Greenberg G. R. Evidence for a complex regulating the in vivo activities of early enzymes induced by bacteriophage T4. J Biol Chem. 1974 Dec 10;249(23):7613–7622. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES